The impact of dual antiplatelet therapy duration on primary composite endpoint after drug-eluting stent implantation: A meta-analysis of 10 randomized trials-Reference-Cited by-同舟云学术

The impact of dual antiplatelet therapy duration on primary composite endpoint after drug-eluting stent implantation: A meta-analysis of 10 randomized trials

Published:2016-01 Issue: Volume:202 Page:504-506
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Pang Si,Shi Shun-Yi,Zhang Yao-Jun,Iqbal Javaid,Chen Xiao-Yun,Ren Xiao-Min,Zhu Hao,Zeng Ya-Ping,Bioh Gabriel,Bourantas Christos V.,Xu Bo,Serruys Patrick W.,Chen Shao-Liang^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference5 articles.

1. 2014 ESC/EACTS Guidelines on myocardial revascularization

2. Twelve or 30months of dual antiplatelet therapy after drug-eluting stents;Mauri;N. Engl. J. Med.,2014

3. Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation: A Systematic Review and Meta-analysis of Randomized Controlled Trials;Giustino,2015

4. The effect of clopidogrel on platelet activity in patients with and without type-2 diabetes mellitus: a comparative study;Schuette;Cardiovasc. Diabetol.,2015

5. Relation of aspirin response to age in patients with stable coronary artery disease;Vaturi;Am. J. Cardiol.,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Duration of Dual Antiplatelet Therapy in Patients With Ischemic Heart Disease After Implantation of Endovascular Stents;Kardiologiia;2018

2. Clinical approach on challenge and desensitization procedures with aspirin in patients with ischemic heart disease and nonsteroidal anti-inflammatory drug hypersensitivity;Allergy;2016-11-28